Literature DB >> 1750279

Epidemiological designs in radioepidemiological research.

E Cardis1, J Estève.   

Abstract

Most of the information currently available on radiation effects comes from the observation of individuals who received high doses, either from one acute exposure or a series of exposures. Because of the uncertainties in extrapolating risks from these studies to the exposure circumstances of most cancers today (in particular, low-level environmental exposure), direct epidemiologic studies of populations receiving low doses chronically are needed. The effects which we want to quantify are likely to be small, however, and extreme care must therefore be put into the design of such studies if they are to be informative for risk assessment purposes. The areas of particular importance in designing risk assessment studies are reviewed. The advantages and limitations of various epidemiological study designs, and the problems and importance of dosimetry are discussed. Examples from the recent epidemiological literature are presented to illustrate the discussion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750279     DOI: 10.1007/bf01359158

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  10 in total

1.  Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis.

Authors:  Z Hrubec; J D Boice; R R Monson; M Rosenstein
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

2.  Analyses of combined mortality data on workers at the Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Nuclear Weapons Plant.

Authors:  E S Gilbert; S A Fry; L D Wiggs; G L Voelz; D L Cragle; G R Petersen
Journal:  Radiat Res       Date:  1989-10       Impact factor: 2.841

Review 3.  Estimating human cancer risk from the results of animal experiments: relationship between mechanism and dose-rate and dose.

Authors:  H Vainio; E Cardis
Journal:  Am J Ind Med       Date:  1992       Impact factor: 2.214

4.  Tissue doses from radiotherapy of cancer of the uterine cervix.

Authors:  M Stovall; S A Smith; M Rosenstein
Journal:  Med Phys       Date:  1989 Sep-Oct       Impact factor: 4.071

5.  Radiation dose and second cancer risk in patients treated for cancer of the cervix.

Authors:  J D Boice; G Engholm; R A Kleinerman; M Blettner; M Stovall; H Lisco; W C Moloney; D F Austin; A Bosch; D L Cookfair; E T Krementz; H B Latourette; J A Merrill; L J Peters; M D Schulz; H H Storm; E Bjorkholm; F Pettersson; C M Janine Bell; M P Coleman; P Fraser; F E Neal; P Prior; N W Choi; T G Hislop; M Koch; N Kreiger; D Robb; D Robson; D H Thomson; H Lochmuller; D von Fournier; R Frischkorn; K E Kjørstad; A Rimpela; M H Pejovic; V P Kirn; H Stankusova; F Berrino; K Sigurdsson; G B Hutchison; B MacMahon
Journal:  Radiat Res       Date:  1988-10       Impact factor: 2.841

6.  Breast cancer among women given X-ray therapy for acute postpartum mastitis.

Authors:  R E Shore; N Hildreth; E Woodard; P Dvoretsky; L Hempelmann; B Pasternack
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

7.  Further assessment of the effects of occupational radiation exposure in the United Kingdom Atomic Energy Authority mortality study.

Authors:  H Inskip; V Beral; P Fraser; M Booth; D Coleman; A Brown
Journal:  Br J Ind Med       Date:  1987-03

8.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).

Authors:  Y Shimizu; H Kato; W J Schull
Journal:  Radiat Res       Date:  1990-02       Impact factor: 2.841

9.  Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis.

Authors:  A B Miller; G R Howe; G J Sherman; J P Lindsay; M J Yaffe; P J Dinner; H A Risch; D L Preston
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

10.  Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis.

Authors:  S C Darby; R Doll; S K Gill; P G Smith
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.